+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Age-related cancer detection rate and costs for one cancer detected in one screening by immunochemical fecal occult blood test



Age-related cancer detection rate and costs for one cancer detected in one screening by immunochemical fecal occult blood test



Diseases of the Colon and Rectum 44(11): 1696-1699



This study was performed to assess, from the aspects of screening efficiency and cost-effectiveness, the optimal lower limit of age in immunochemical occult blood screening for colorectal cancer. Seven thousand four hundred asymptomatic individuals were the subjects of this study. They gave samples for an immunochemical fecal occult blood test (OC-Hemodia), and colonoscopy was performed during a medical checkup. They were divided into three groups according to their ages: younger (40-49), middle (50-59), and older (60+) groups. The detection rate for colorectal cancer and the average costs to detect one patient with colorectal cancer were evaluated among the three groups. The detection rate for colorectal cancer and the average costs to detect one cancer patient were calculated as 0.3 percent and $6024 for the younger group, 1.6 percent and $1425 for the middle group, and 1.7 percent and $1410 for the older group, respectively. The cancer detection rate was significantly different between the younger and middle groups (P < 0.05) and between the younger and older groups (P < 0.05). This analysis suggests that the subjects aged less than 50 have some disadvantage when carrying out the immunochemical fecal occult blood test, OC-Hemodia for colorectal cancer screening, from the aspects of screening efficiency and cost-effectiveness.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045190322

Download citation: RISBibTeXText

PMID: 11711744

DOI: 10.1007/bf02234392


Related references

A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study. International Journal of Cancer 128(10): 2415-2424, 2011

Comparisons of cancer detection rate and costs for one cancer detected among different age-cohorts in immunochemical occult blood screening. Journal of Cancer Research & Clinical Oncology 127(7): 439-443, 2001

Immunochemical detection of fecal occult blood . The fecal smear punch-disc test: A new non-invasive screening test for colorectal cancer. Cancer 45(S5): 1099-1102, 1980

Immunochemical detection of fecal occult blood--the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer. Cancer 45(5 Suppl): 1099-1102, 1980

Survival benefit for patients with colorectal cancer detected by population-based screening program using an immunochemical fecal occult blood test. International Journal of Oncology 9(4): 685-691, 1996

Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program. Clinical Epidemiology 10: 1649-1655, 2018

Advantage of immunochemical fecal occult blood test in screening for colorectal cancer. Bulletin du Cancer 92(10): 885-890, 2005

Immunochemical fecal occult blood test is inadequate for screening test of stomach cancer. Digestive Diseases & Sciences 45(11): 2195-2198, 2000

Immunochemical fecal occult blood test is inadequate for screening test of stomach cancer. Digestive Diseases and Sciences 45(11): 2195-2198, 2000

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening. Plos one 12(3): E0172864, 2017

Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 2: Rate of a false-negative occult blood test. Zeitschrift für Arztliche Fortbildung 81(20): 1057-1059, 1987

Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening. Journal of Digestive Diseases 20(2): 78-82, 2019

Clinical impact of the immunochemical fecal occult blood test for colorectal cancer screening in Brazil. Annals of Gastroenterology 30(4): 442-445, 2017

Immunochemical fecal occult blood test for detection of rectosigmoid cancer in asymptomatic adults. Gastroenterology 114(4 Part 2): A625, 1998

Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study. European Journal of Gastroenterology and Hepatology 21(9): 1062-1067, 2009